Literature DB >> 27469387

Retinopathy of prematurity screening leading to cardiopulmonary arrest: fatal complication of a benign procedure.

Yashwant Agrawal1, Sandeep Patri2, Jagadeesh K Kalavakunta3, Vishal Gupta3.   

Abstract

A 6-week-old female infant born at 31 weeks of gestation was brought to the ophthalmology office for retinopathy of prematurity (ROP) screening. One drop of phenylephrine (2.5%) and tropicamide (1%) ophthalmic solution was instilled in each eye for ROP evaluation. She was breast fed about 5 min after receiving the medication. She was covered in a blanket and soon her mother could not feel her suckling. Cardiopulmonary resuscitation was initiated with return of spontaneous circulation in 1-2 min. She was admitted to the paediatric intensive care unit and monitored overnight. After an uncomplicated hospital course, she was discharged the following day. It was determined that the eye drops had induced cardiopulmonary arrest (CPA) as apnoea and bradycardia of prematurity resolve by 36 weeks and CPA occurred within minutes of the medication administration. Identification of CPA, prompt intervention and awareness of the offending agent is of prime importance in management of such complications. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27469387      PMCID: PMC4986147          DOI: 10.1136/bcr-2016-216594

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

Review 1.  Cardiovascular effects of commonly used ophthalmic medications.

Authors:  Y Shiuey; M J Eisenberg
Journal:  Clin Cardiol       Date:  1996-01       Impact factor: 2.882

2.  Reduction in mydriatic drop size in premature infants.

Authors:  S Wheatcroft; A Sharma; J McAllister
Journal:  Br J Ophthalmol       Date:  1993-06       Impact factor: 4.638

3.  Physiologic effects of retinopathy of prematurity screening examinations.

Authors:  Anita J Mitchell; Angela Green; Debra A Jeffs; Paula K Roberson
Journal:  Adv Neonatal Care       Date:  2011-08       Impact factor: 1.968

4.  Apnea and bradycardia in two premature infants during routine outpatient retinopathy of prematurity screening.

Authors:  Michael G Wood; Lawrence M Kaufman
Journal:  J AAPOS       Date:  2009-05-30       Impact factor: 1.220

5.  Additive mydriatic effect of 2.5% phenylephrine and 0.5% tropicamide eyedrops in premature babies.

Authors:  B W Fleck; B Dhillon; A Mitchell
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1994 Mar-Apr       Impact factor: 1.402

6.  A mydriatic eye-drop combination without systemic effects for premature infants: a prospective double-blind study.

Authors:  B Bolt; B Benz; F Koerner; E Bossi
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1992 May-Jun       Impact factor: 1.402

  6 in total
  2 in total

1.  N-terminal B-type natriuretic peptide urinary concentrations and retinopathy of prematurity.

Authors:  Christoph Bührer; Ömer Erdeve; Anton van Kaam; Angelika Berger; Evelyn Lechner; Benjamin Bar-Oz; Karel Allegaert; Tom Stiris; İstemi Han Çelik; Janet Berrington
Journal:  Pediatr Res       Date:  2017-08-16       Impact factor: 3.756

2.  Acute drug reaction to phenylephrine and tropicamide collyrium in a late-preterm newborn: a case report.

Authors:  Francesco Baldo; Laura Travan
Journal:  BMC Pediatr       Date:  2022-07-07       Impact factor: 2.567

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.